Clinical Trial Update: Indapamide and Chlorthalidone to Reduce Urine Supersaturation for Kidney Stone Prevention [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating whether combining indapamide and chlorthalidone can reduce urine supersaturation to prevent kidney stones. The study is c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis

Drugs mentioned

• Chlorthalidone (chlorthalidone)
• Indapamide (Indapamide)

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Kidney Stone | Phase 2 | Status: RECRUITING